Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0SR4G
|
||||
Former ID |
DIB005924
|
||||
Drug Name |
ONT-093
|
||||
Synonyms |
MDR inhibitors, Ontogen; OC-144-093
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 1 | [546965] | ||
Company |
Ontogen Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C32H38N4O
|
||||
Canonical SMILES |
n1c(c([nH]c1c1ccc(/C=C/COCC)cc1)c1ccc(NC(C)C)cc1)c1ccc(<br />NC(C)C)cc1
|
||||
CAS Number |
CAS 216227-54-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Multidrug resistance protein 1 | Target Info | Inhibitor | [527635] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.